Neurology Today in 5

著者： American Academy of Neurology
無料で聴く

  • サマリー

  • Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.
    2024
    続きを読む 一部表示

あらすじ・解説

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.
2024
衛生・健康的な生活 身体的病い・疾患
続きを読む 一部表示
エピソード
  • Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty

    Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty
    2024/12/19

    In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on proposed updated criteria for diagnosing MS before symptoms manifest, the use of large language models to address administrative burden with electronic medical records, and the growth of training programs in neonatal neurocritical care.
    続きを読む 一部表示
    5 分
  • 3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration

    3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration
    2024/12/05

    In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on a study highlighting three-year outcomes for patients with anti-NMDAR encephalitis, an analysis comparing the diagnostic efficacy of skin biopsies vs. CSF tests for human prion diseases, and the ways in which a graduate degree in public health and/or business administration can shape career pathways for neurologists.

    続きを読む 一部表示
    5 分
  • Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer’s

    Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer’s
    2024/11/21

    In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the higher risk for cardiovascular effects with certain antiseizure therapies on adults with epilepsy, the impact of social determinants of health on children with MS, and the status of coverage for blood-based tests for Alzheimer’s disease.
    続きを読む 一部表示
    5 分

Neurology Today in 5に寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。